Chimerix to Announce Second Quarter 2018 Financial Results on August 8, 2018
August 01 2018 - 8:00AM
Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing
novel antivirals to address unmet medical needs, today
announced that it will host a live conference call and audio
webcast on Wednesday, August 8, 2018 at 8:30 a.m. ET to report
financial results for the second quarter ended June 30, 2018, and
to provide a business overview.
To access the live conference call, please dial (877) 354-4056
(domestic) or (678) 809-1043 (international) at least five minutes
prior to the start time, and refer to conference ID 2976768. A live
audio webcast of the call will also be available on the Investors’
section of the Company's website, www.chimerix.com. An archived
webcast will be available on the Chimerix website approximately two
hours after the event.
About ChimerixChimerix is a
biopharmaceutical company dedicated to discovering, developing and
commercializing medicines that improve outcomes for
immunocompromised patients. Chimerix's proprietary lipid
conjugate technology and compound library have produced
brincidofovir (BCV, CMX001); CMX157, which was licensed
to ContraVir Pharmaceuticals; and CMX521, the first
clinical-stage direct-acting antiviral for the treatment and
prevention of norovirus. For further information, please
visit Chimerix's website, www.chimerix.com.
CONTACT:
Investor
Relations:
Michelle LaSpaluto (919) 972-7115 ir@chimerix.com or Will
O’Connor Stern Investor Relations Will@sternir.com
212-362-1200
Media: Becky Vonsiatsky W2O Group bvonsiatsky@w2ogroup.com
413-478-2003
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024